Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  PI3K-beta inhibitor GSK2636771
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 200331, NCI-2015-01117, NCT02215096
Start Over